239 results
Page 3 of 12
6-K
EX-99
ypng dn8qawbhr6r
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
mw0fa7bngvi5
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
ohrmj1 3q2xny3
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
sfq6b5bxw865f3otpx
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
05qqqn
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
rm1tetbgsp
16 Dec 20
Current report (foreign)
8:00am
6-K
EX-99
7tgh65nocv3qlxyk
16 Dec 20
BioLineRx Announces Final Results from Phase 2a
6:02am
6-K
EX-99
5via4zhw6k3gqsub41
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
6-K
EX-99
9tm4592
18 Nov 20
BioLineRx Announces Initiation of Phase 1b Clinical Trial
7:09am
424B5
jhi4zxs ruv5q12vgwgl
13 Nov 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-1
zdu36f6qj nhp
30 Oct 20
BioLineRx Announces Positive Results from Interim Analysis of
7:09am
6-K
EX-99
hblwilx f5ym7popa
29 Oct 20
BioLineRx Announces Initiation of Phase 2 Clinical Trial
8:45am
6-K
EX-10.1
8iqbhfaufng
25 Sep 20
Current report (foreign)
4:33pm
424B5
fvmo ixruaab
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
64oyypkrz9
19 Aug 20
BioLineRx Achieves Enrollment Target in Phase 3
7:08am
6-K
EX-99
0y8g5bxt2k5m
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B5
ovx7nb
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
zvv424n
3 Jun 20
Current report (foreign)
8:30am
424B5
v5vbps uswnp6fz
28 May 20
Prospectus supplement for primary offering
12:00pm